Proponents herald the practice as a free-market approach to providing medical care, while critics say it could widen health ...

The board of Quest Diagnostics Incorporated ( NYSE:DGX ) has announced that it will be paying its dividend of $0.80 ...

Baird raised the firm’s price target on Quest Diagnostics (DGX) to $191 from $190 and keeps an Outperform rating on the shares. The firm ...

In a report released today, David S Macdonald from Truist Financial maintained a Hold rating on Quest Diagnostics (DGX – Research Report). The ...

Quest Diagnostics, GE Healthcare and Synchron were among the medtech firms that used Nvidia’s GTC 2025 conference to share ...

Quest Diagnostics adjusts Q1 revenue & EPS outlook due to weather impact, projects 4-5% CAGR revenue growth beyond 2025. Read ...

Investing.com -- Quest Diagnostics (NYSE: NYSE: DGX ), a prominent player in diagnostic information services, announced today ...

Quest Diagnostics announced it is teaming up with Google Cloud to develop artificial intelligence programs that can ...

This was the stock's second consecutive day of losses.

This was the stock's third consecutive day of gains.

Shares of Quest Diagnostics (NYSE: NYSE:DGX) tumbled 4.75% today after the company provided long-term guidance that failed to meet investor expectations. Despite reaffirming its full-year 2025 ...

Quest said it aims through the collaboration to streamline data management, improve data analytics, and personalize the experiences of its patients.